268 related articles for article (PubMed ID: 20028780)
1. Genetic analysis of extensively drug-resistant Mycobacterium tuberculosis strains in Lisbon, Portugal.
Perdigão J; Macedo R; Malaquias A; Ferreira A; Brum L; Portugal I
J Antimicrob Chemother; 2010 Feb; 65(2):224-7. PubMed ID: 20028780
[TBL] [Abstract][Full Text] [Related]
2. From multidrug-resistant to extensively drug-resistant tuberculosis in Lisbon, Portugal: the stepwise mode of resistance acquisition.
Perdigão J; Macedo R; Silva C; Machado D; Couto I; Viveiros M; Jordao L; Portugal I
J Antimicrob Chemother; 2013 Jan; 68(1):27-33. PubMed ID: 23054995
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis drug-resistance in Lisbon, Portugal: a 6-year overview.
Perdigão J; Macedo R; Silva C; Pinto C; Furtado C; Brum L; Portugal I
Clin Microbiol Infect; 2011 Sep; 17(9):1397-402. PubMed ID: 20731680
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
5. Novel multiplex allele-specific PCR assays for the detection of resistance to second-line drugs in Mycobacterium tuberculosis.
Evans J; Segal H
J Antimicrob Chemother; 2010 May; 65(5):897-900. PubMed ID: 20185419
[TBL] [Abstract][Full Text] [Related]
6. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco.
Oudghiri A; Karimi H; Chetioui F; Zakham F; Bourkadi JE; Elmessaoudi MD; Laglaoui A; Chaoui I; El Mzibri M
BMC Infect Dis; 2018 Feb; 18(1):98. PubMed ID: 29486710
[TBL] [Abstract][Full Text] [Related]
8. [Future prospects of molecular epidemiology in tuberculosis].
Matsumoto T; Iwamoto T
Kekkaku; 2009 Dec; 84(12):783-4. PubMed ID: 20077862
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-resistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective.
Perdigão J; Macedo R; João I; Fernandes E; Brum L; Portugal I
Microb Drug Resist; 2008 Jun; 14(2):133-43. PubMed ID: 18573039
[TBL] [Abstract][Full Text] [Related]
10. Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.
Mlambo CK; Warren RM; Poswa X; Victor TC; Duse AG; Marais E
Int J Tuberc Lung Dis; 2008 Jan; 12(1):99-104. PubMed ID: 18173885
[TBL] [Abstract][Full Text] [Related]
11. Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.
Singh AK; Maurya AK; Kant S; Umrao J; Kushwaha RA; Nag VL; Dhole TN
J Postgrad Med; 2013; 59(3):179-85. PubMed ID: 24029194
[TBL] [Abstract][Full Text] [Related]
12. Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore.
Sun YJ; Luo JT; Wong SY; Lee AS
Clin Microbiol Infect; 2010 Mar; 16(3):287-9. PubMed ID: 19519851
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from high prevalence tuberculosis states in Mexico.
Juarez-Eusebio DM; Munro-Rojas D; Muñiz-Salazar R; Laniado-Laborín R; Martinez-Guarneros JA; Flores-López CA; Zenteno-Cuevas R
Infect Genet Evol; 2017 Nov; 55():384-391. PubMed ID: 27637930
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the isoniazid-resistant mutation katGS315T and the prevalence of MDR-/XDR-TB in Osaka, Japan.
Ano H; Matsumoto T; Suetake T; Nagai T; Tamura Y; Takamatsu I; Iwasaki T; Matsuoka H; Sasada S; Tetsumoto S; Tsuyuguchi I; Kusunoki Y; Takashima T
Int J Tuberc Lung Dis; 2008 Nov; 12(11):1300-5. PubMed ID: 18926041
[TBL] [Abstract][Full Text] [Related]
15. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
[TBL] [Abstract][Full Text] [Related]
16. Implication of the RD(Rio) Mycobacterium tuberculosis sublineage in multidrug resistant tuberculosis in Portugal.
David S; Duarte EL; Leite CQ; Ribeiro JN; Maio JN; Paixão E; Portugal C; Sancho L; Germano de Sousa J
Infect Genet Evol; 2012 Oct; 12(7):1362-7. PubMed ID: 22569099
[TBL] [Abstract][Full Text] [Related]
17. Extensively drug-resistant tuberculosis: epidemiology and management challenges.
Dheda K; Warren RM; Zumla A; Grobusch MP
Infect Dis Clin North Am; 2010 Sep; 24(3):705-25. PubMed ID: 20674800
[TBL] [Abstract][Full Text] [Related]
18. [The effects of gene mutation related to drug resistance and drug efflux pump in extensively drug-resistant tuberculosis clinical isolates].
Cui ZL; Wang XL; Wang J; Lu JM; Hu ZY
Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):505-9. PubMed ID: 20979796
[TBL] [Abstract][Full Text] [Related]
19. Extensively drug-resistant tuberculosis: current challenges and threats.
Jain A; Mondal R
FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
[TBL] [Abstract][Full Text] [Related]
20. Genotypic diversity of multidrug-, quinolone- and extensively drug-resistant Mycobacterium tuberculosis isolates in Thailand.
Disratthakit A; Meada S; Prammananan T; Thaipisuttikul I; Doi N; Chaiprasert A
Infect Genet Evol; 2015 Jun; 32():432-9. PubMed ID: 25847698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
